Neurocrine Biosciences (NBIX) Misses Q4 EPS by 11c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/24/2026

1. RNG
2. DECK
3. WDC
4. BYD
5. WCN
6. SPOT
7. BMY
8. SPY
9. FIX
10. TSCO

Go back to Neurocrine Biosciences (NBIX) Misses Q4 EPS by 11c

Neurocrine Bio. (NBIX) PT Raised to $100 at Oppenheimer

February 14, 2018 6:21 AM EST

Oppenheimer raised its price target on Neurocrine Bio. (NASDAQ: NBIX) to $100.00 (from $95.00) while maintaining a Outperform rating following Q4 results.

Analyst Jay Olson commented, "NBIX shares have outperformed YTD (+8% vs. NBI +1% and S&P 500 flat), largely driven by impressive 4Q17 sales of... More